Cargando…
Production of Functional Glucagon-Secreting α-Cells From Human Embryonic Stem Cells
OBJECTIVE: Differentiation of human embryonic stem (hES) cells to fully developed cell types holds great therapeutic promise. Despite significant progress, the conversion of hES cells to stable, fully differentiated endocrine cells that exhibit physiologically regulated hormone secretion has not yet...
Autores principales: | Rezania, Alireza, Riedel, Michael J., Wideman, Rhonda D., Karanu, Francis, Ao, Ziliang, Warnock, Garth L., Kieffer, Timothy J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012176/ https://www.ncbi.nlm.nih.gov/pubmed/20971966 http://dx.doi.org/10.2337/db10-0573 |
Ejemplares similares
-
Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice
por: Rezania, Alireza, et al.
Publicado: (2012) -
Clinical Application of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
por: Cho, Young Min, et al.
Publicado: (2013) -
Statistical approaches and software for clustering islet cell functional heterogeneity
por: Wills, Quin F., et al.
Publicado: (2016) -
Local Expression of Indoleamine 2,3 Dioxygenase in Syngeneic Fibroblasts Significantly Prolongs Survival of an Engineered Three-Dimensional Islet Allograft
por: Jalili, Reza B., et al.
Publicado: (2010) -
AAV GCG-EGFP, a new tool to identify glucagon-secreting α-cells
por: Tudurí, Eva, et al.
Publicado: (2019)